Noting the lack of adequate price controls on medicines, the Supreme Court recently flagged the wide disparity between the Price to Retailer (PTR) and Maximum Retail Price (MRP) of life-saving drugs, particularly cancer medicines.

A bench of Justices Vikram Nath and Sandeep Mehta questioned how a 10-fold difference between the PTR and MRP could be permitted and whether there should be a fixed criterion to limit the disparity. Referring to the impact of such pricing on patients, Justice Mehta described the practice as “absolute rampage and carnage and broad daylight dacoity with the patients.”

For more details, check out the full story on the link mentioned below:

Fraud, broad daylight dacoity with patients: SC laments Exorbitant medicine pricing, flags tenfold retail price gap in essential cancer drugs

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Anshika Mishra

Anshika Mishra is a dedicated scholar pursuing a Masters in Biotechnology, driven by a profound passion for exploring the intersection of science and healthcare. Having embarked on this academic journey with a passion to make meaningful contributions to the medical field, Anshika joined Medical Dialogues in 2023 to further delve into the realms of healthcare journalism.

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .